- Filed
- Jul 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jul 8, 2024 | 307.97M sh |
| Long Term Debt | Q1 2025 · May 31, 2024 | $1.04B |
| Long Term Debt | Q1 2025 · Feb 29, 2024 | $1.04B |
| Short Term Debt | Q1 2025 · May 31, 2024 | $11.28M |
| Short Term Debt | Q1 2025 · Feb 29, 2024 | $11.27M |
| Stockholders Equity | Q1 2025 · May 31, 2024 | $1.46B |
| Stockholders Equity | Q1 2025 · Feb 29, 2024 | $1.48B |
| Current Liabilities | Q1 2025 · May 31, 2024 | $313.54M |
| Current Liabilities | Q1 2025 · Feb 29, 2024 | $338.97M |
| Total Liabilities | Q1 2025 · May 31, 2024 | $1.52B |
| Total Liabilities | Q1 2025 · Feb 29, 2024 | $1.56B |
| Current Assets | Q1 2025 · May 31, 2024 | $320.37M |
| Current Assets | Q1 2025 · Feb 29, 2024 | $339.44M |
| Total Assets | Q1 2025 · May 31, 2024 | $3.08B |
| Total Assets | Q1 2025 · Feb 29, 2024 | $3.14B |
| Cash And Equivalents | Q1 2025 · Feb 29, 2024 | $134.48M |
| Cash And Equivalents | Q1 2025 · May 31, 2023 | $119.54M |
| Shares Diluted | Q1 2025 · May 31, 2023 | 302.5M sh |
| Capex | Q1 2025 · May 31, 2023 | $6.55M |
| Operating Cash Flow | Q1 2025 · May 31, 2023 | $36.46M |
| Eps Diluted | Q1 2025 · May 31, 2023 | −$1.08 |
| Eps Basic | Q1 2025 · May 31, 2023 | −$1.08 |
| Sga Expense restated | Q1 2025 · May 31, 2023 | $22.13M |
| Rd Expense | Q1 2025 · May 31, 2023 | $25.87M |
| Net Income | Q1 2025 · May 31, 2023 | −$325.4M |
| Operating Income | Q1 2025 · May 31, 2023 | −$422.69M |
| Gross Profit | Q1 2025 · May 31, 2023 | $79.42M |
| Cost Of Revenue | Q1 2025 · May 31, 2023 | $80.7M |
| Revenue | Q1 2025 · May 31, 2023 | $160.12M |